Molecule That ‘Lit Up’ Ovarian Cancer Cells During Surgery Put on Fast Track by FDA

Molecule That ‘Lit Up’ Ovarian Cancer Cells During Surgery Put on Fast Track by FDA
Surgery is the primary treatment for a large number of solid cancers, but the disease often comes back because surgeons miss tiny clusters of cells not seen during the procedure or in pre-operative images. Now, the U.S. Food and Drug Administration has granted Fast Track status to a new molecule designed to “light up” cancer cells, so that surgeons can

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *